tuhurabio.com (HURA): Nilai pasar

Logo grafis TuHURA Biosciences, Inc. (HURA)

TuHURA Biosciences possesses significant pricing power due to its unique IFx vaccines, which trigger the immune system to destroy tumors. The current market quotes on GURU.Markets visualized below show a capitalization of 0.13. Business development relies on test results, ignoring market cycles. The constant demand for advanced therapies transforms this sector into a resilient defensive asset, independent of the global economy.

TuHURA Biosciences - Kapitalisasi pasar HURA (periode 04.07.2022 - 22.10.2026)

Rincian metrik lan analitis perusahaan tuhurabio.com (HURA)

Pambiji fundamental perusahaan:TuHURA HURA
Sampel barang TuHURA Biosciences

Market capitalization determines the total value of all a company's shares, reflecting the market valuation of the business. Comparing this volume with competitors allows an investor to determine the scale of the issuer. By analyzing the market capitalization of TuHURA Biosciences, Inc. (HURA), one can track the current value of 0.13. The trend of this indicator here directly depends on successes in the development of oncology drugs. A failure in clinical trials or a funding deficit will inevitably lead to a sharp reduction in this value.

Pesaing TuHURA Biosciences, Inc. (HURA)

BeiGene - Biji pasar|Kapitalisasi pasar Halozyme Therapeutics, Inc. HALO|RVMD - Nilai pasar|Nilai pasar AAPG (Ascentage Pharma Corp)|CGON: Kapitalisasi pasar|urogen.com (URGN) - Kapitalisasi pasar|BCAX (Bicara Therapeutics) - Kapitalisasi pasar|Biji pasar Personalis Inc (PSNL)|Kapitalisasi pasar ERAS|Kapitalisasi pasar Delcath Corp (DCTH)|Nilai pasar Y-mAbs Therapeutics YMAB|AURA: Kapitalisasi pasar|Candel - Kapitalisasi pasar|Accuray Inc (ARAY) - Biji pasar|SLS: Kapitalisasi pasar|Nilai pasar Actuate Therapeutics Inc (ACTU)|Nilai pasar Citius Oncology, Inc.|TARA: Nilai pasar|Biji pasar FATE (Fate Therapeutics)|WHWK (aadibio.com) - Nilai pasar|Kapitalisasi pasar TCRX (TScan Therapeutics, Inc.)|CSBR - Biji pasar|XBIT: Biji pasar|CVM - Kapitalisasi pasar|OS Therapies (OSTX) - Nilai pasar|Radiopharm Theranostics Ltd - Nilai pasar|ARTV (Artiva Biotherapeutics Inc.) - Kapitalisasi pasar|Nilai pasar Adlai Nortye Limited ANL|Biji pasar VERU (Veru Inc.)|Nilai pasar TPST|Xilio Therapeutics - Biji pasar|Kapitalisasi pasar Renovaro Biosciences RENB|Mural Bio - Kapitalisasi pasar|Nilai pasar KAPA (Kairos Pharma Ltd)|OKUR (onkuretherapeutics.com) - Biji pasar|CytoMed Therapeutics Limited (GDTC) - Kapitalisasi pasar|Nilai pasar Curis Inc.|APLM: Nilai pasar|Kapitalisasi pasar THAR|Kapitalisasi pasar advanbiomed.com (ADVB)|Genprex, Inc. - Biji pasar|Nilai pasar CLDI|Sunshine Biopharma - Kapitalisasi pasar|XBIO: Nilai pasar|SLRX: Kapitalisasi pasar|PPBT - Kapitalisasi pasar|Nilai pasar American Oncology Network Inc|Nilai pasar beigene.com BGNE|Nilai pasar Checkpoint Therapeutics, Inc. (CKPT)|Kapitalisasi pasar Elevation Oncology Inc.|Kapitalisasi pasar ICAD (iCAD)|IKNA - Biji pasar|Notable Labs, Ltd. - Kapitalisasi pasar|Kapitalisasi pasar Viracta Therapeutics VIRX|MOR: Kapitalisasi pasar|Nilai pasar NAYA Biosciences Inc (NAYA)|Nilai pasar Ascentage Pharma Group Ltd